Tuesday, July 06, 2004

Europe's patent office hears genetic rodent appeal

The European Patent Office began hearing Monday an appeal against a patent issued for a genetically modified rodent that its inventors claim can be useful in cancer research.
The appeal against Harvard University's so-called Oncomouse patent, the first ever granted for a transgenic animal, was launched by six organisations from Austria, Britain, Germany and Switzerland.

Using the Oncomouse technique, scientists can alter a gene in the rodents and make them more likely to develop tumours, which means they can be used to test whether a material might contain carcinogens.

The six groups claim that the patent is "contrary to public order and morality" and that it does not meet some of the requirements of patent law.

The environmentalist group Greenpeace, which is not involved in the appeal, also staged a protest as the first day of the oral hearings got underway at EPO headquarters in Munich, southern Germany.

Seja o primeiro a comentar

DISCLAIMER

This Blog/Web Site ("Blog") is for educational purposes only and is not legal advice. Use of the Blog does not create any attorney-client relationship between you and Peter Zura or his firm. Persons requiring legal advice should contact a licensed attorney in your state. Any comment posted on the Blog can be read by any Blog visitor; do not post confidential or sensitive information. Any links from another site to the Blog are beyond the control of Peter Zura and does not convey his, or his past or present employer(s) approval, support, endorsement or any relationship to any site or organization.

The 271 Patent Blog © 2008. Template by Dicas Blogger.

TOPO